Sialorrhea — Therapeutic Drug Options

@article{Tscheng2002SialorrheaT,
  title={Sialorrhea — Therapeutic Drug Options},
  author={Dorothy Tscheng},
  journal={Annals of Pharmacotherapy},
  year={2002},
  volume={36},
  pages={1785 - 1790}
}
OBJECTIVE: To review the efficacy and safety of various drug treatments for sialorrhea. Pharmacotherapy for drug-induced sialorrhea is not addressed. DATA SOURCES: Clinical studies were identified using PubMed (1966–October 2001). Key search terms included sialorrhea and drug therapy. DATA SYNTHESIS: Sialorrhea is a social and physical detriment to patients. Drug treatment, although not necessarily the treatment of choice for all patients, can offer some symptom relief. CONCLUSIONS: Literature… 
Clozapine-induced sialorrhea: pathophysiology and management strategies
TLDR
Judicious use of pharmacological agents along with behavioral methods will reduce this troublesome side effect and enhance compliance and no drug has been found to be superior.
Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations
  • E. Tan
  • Medicine, Biology
    European journal of neurology
  • 2006
TLDR
Based on open‐label and controlled studies, botulinum toxin can be used to improve sialorrhea in patients with Parkinson's disease, parkinsonian syndromes, motor neuron disease and cerebral palsy.
When saliva becomes a problem: the challenges and palliative care for patients with sialorrhea.
TLDR
The purpose of this article is to present some background and etiology behind sialorrhea as well as present treatment options-non-pharmacologic, pharmacologic, surgical, and radiotherapeutic-that can help to ameliorate symptoms and improve quality of life for patients.
Treating sialorrhea with transdermal scopolamine. Exploiting a side effect to treat an uncommon symptom in cancer patients
TLDR
Anticholinergic drugs are classified as secondary options in the treatment of sialorrhea of patients with Parkinson’s disease or cerebral palsy, but could be useful in cancer patients with bowel subocclusion, as the reduction of gastrointestinal secretions and intestinal motility could be effective in controlling nausea, vomiting, and abdominal pain.
Controversies in the Management of Pediatric Sialorrhea
  • S. Daniel
  • Medicine
    Current Otorhinolaryngology Reports
  • 2015
TLDR
This comprehensive review will discuss current management options used in the treatment of sialorrhea, including rehabilitative options such as oral-motor and behavior therapy; medical treatments such as anti-cholinergics and botulinum toxin; and surgical interventions intended to either decrease salivary secretion or divert Salivary flow.
Sublingual atropine drops for the treatment of pediatric sialorrhea.
  • A. Rapoport
  • Medicine
    Journal of pain and symptom management
  • 2010
Sialorrhea in Parkinson's disease: A review
TLDR
Current knowledge regarding the frequency, etiology, assessment, and treatment of sialorrhea in Parkinson's disease is reviewed.
Salivary gland application of botulinum toxin for the treatment of sialorrhea.
TLDR
The effective therapeutic dose and ideal form of application remain to be established, and require the conduction of further controlled clinical trials involving large sample sizes.
Salivary gland application of botulinum toxin for the treatment of sialorrhea
TLDR
The effective therapeutic dose and ideal form of application remain to be established, and require the conduction of further controlled clinical trials involving large sample sizes.
Adverse drug reactions in the oral cavity
TLDR
This narrative review aims to identify all the major hard and soft tissue manifestations produced by drugs in the oral cavity, the drugs causing them and their prevention and treatment.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 21 REFERENCES
Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
TLDR
Glycopyrrolate in doses of 0.10 mg/kg per dose is effective at controlling sialorrhea in children with developmental disabilities and even at low doses, 20% of children may exhibit adverse effects severe enough to require discontinuation.
Use of Glycopyrrolate and Other Anticholinergic Medications for Sialorrhea in Children with Cerebral Palsy
TLDR
Preliminary data indicate a trial of glycopyrrolate should be considered in children with cerebral palsy where drooling is a significant problem and side effects surfaced in almost half (44%) of the patients.
Clozapine-Induced Hypersalivation
TLDR
It is unclear whether clozapine increases salivation through its muscarinic M4 receptor activation and/or blockade of α2-adrenoceptors, or by causing a distortion in swallowing reflex.
Glycopyrrolate treatment of chronic drooling.
TLDR
Glycopyrrolate therapy safely and effectively decreased but rarely abolished drooling in patients with cerebral palsy and related neurodevelopmental disabilities.
Preliminary study of glycopyrrolate in the management of drooling.
TLDR
In this preliminary study, glycopyrrolate was found to be an effective and well-tolerated addition to the management of drooling in children with disabilities.
Botulinum toxin is a useful treatment in excessive drooling of saliva
TLDR
Excessive drooling of saliva or hypersialorrhea is a common problem in neurodegenerative disorders such as motor neuron disease or Parkinson′s disease and can facilitate choking, aspiration, and chest infections.
EFFICACY OF BENZTROPINE THERAPY FOR DROOLING
TLDR
It is demonstrated that synthetic anticholinergics can provide an important therapeutic alternative to surgical and behavioral therapies for drooling and conservative response rates, ranged up to 65 to 70 per cent.
Transdermal scopolamine in drooling.
TLDR
Transdermal scopolamine (1.5 mg/2.5 cm2) offers advantages in the treatment of drooling and a distinct reduction of basal salivation was demonstrated in an open trial of six healthy volunteers.
EFFECT OF ANTIREFLUX MEDICATION ON SALIVARY DROOLING IN CHILDREN WITH CEREBRAL PALSY
TLDR
Treatment of pathological GOR did not improve salivary drooling in children with CP and severe drooling and mean drooling quotients and scores for drooling severity and frequency were not significantly different between active medication and placebo.
Management of drooling in individuals with neurodisability: a surgical experience.
TLDR
The pattern of oral-motor function in 26 children studied after SDRSGE surgery suggested that those children with severe impairment of volitional motor function and profuse drooling tended to have a poorer outcome following surgery compared to those with milder impairments.
...
1
2
3
...